Publications

Found 3 results
Author Title [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2022
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers., Lim, Shion A., Zhou Jie, Martinko Alexander J., Wang Yung-Hua, Filippova Ekaterina V., Steri Veronica, Wang Donghui, Remesh Soumya G., Liu Jia, Hann Byron, et al. , J Clin Invest, 2022 Feb 15, Volume 132, Issue 4, (2022)
2021
A T cell redirection platform for co-targeting dual antigens on solid tumors., Enderle, Leonie, Shalaby Karim H., Gorelik Maryna, Weiss Alexander, Blazer Levi L., Paduch Marcin, Cardarelli Lia, Kossiakoff Anthony, Adams Jarrett J., and Sidhu Sachdev S. , MAbs, 2021 Jan-Dec, Volume 13, Issue 1, p.1933690, (2021)
2017
Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody., Rizk, Shahir S., Mukherjee Somnath, Koide Akiko, Koide Shohei, and Kossiakoff Anthony A. , Sci Rep, 2017 04 03, Volume 7, Issue 1, p.556, (2017)

RAN Publications

University of Toronto  UCSF  The University of Chicago  QB3  Chicago Biomedical Consortium